SPEU - ETF AI Analysis
Top Page
SPDR Portfolio Europe ETF (SPEU)
Rating:63Neutral
Price Target:―
Positive Factors
Strong Recent Performance
The ETF has delivered steady gains over the past month, three months, and year to date, showing solid recent momentum.
Leading European Blue-Chip Holdings
Top positions like ASML, HSBC, and several major healthcare and consumer companies have shown strong or steady performance, helping support the fund’s returns.
Low Expense Ratio
The fund’s relatively low annual fee means more of the investment’s growth can stay in investors’ pockets over time.
Negative Factors
Heavy Europe Focus
With most assets in European markets, the ETF is heavily exposed to economic and political developments in Europe, which may limit diversification for investors already holding U.S. or global funds.
Concentrated Country Exposure
Large weights in the UK, France, and Germany mean the fund’s performance is strongly tied to just a few European economies.
Mixed Performance Among Top Holdings
While several major positions have performed well, at least one large holding has shown weak results, which can drag on overall returns if that continues.
SPEU vs. SPDR S&P 500 ETF (SPY)
AUM721.24M
RegionEurope
Expense Ratio0.07%
Beta0.70
IssuerState Street
Inception DateOct 15, 2002
Dividend Yield3.54%
Asset ClassEquity
Index TrackedSTOXX Europe TMI
Share Statistics
EPS (TTM)N/A
Shares OutstandingN/A
10 Day Avg. Volume16,110
30 Day Avg. Volume24,080
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
64.64Price Target Upside― Downside
Rating ConsensusModerate Buy
Number of Analyst Covering1596
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
SPEU Summary
SPEU is the SPDR Portfolio Europe ETF, which follows the STOXX Europe Total Market Index. It gives you broad exposure to European stocks across many countries and industries in a single investment. The fund holds well-known companies like Nestlé, HSBC, and Shell, so you’re getting a mix of consumer, financial, and energy businesses. Someone might invest in SPEU to diversify beyond the U.S. and tap into Europe’s long-term growth potential. A key risk is that European stock prices can rise or fall with the overall market and regional economic conditions.
How much will it cost me?The SPDR Portfolio Europe ETF (SPEU) has an expense ratio of 0.07%, meaning you’ll pay $0.70 per year for every $1,000 invested. This is lower than average because it’s a passively managed fund that tracks an index, which typically involves fewer costs compared to actively managed funds.
What would affect this ETF?The SPDR Portfolio Europe ETF (SPEU) could benefit from positive economic growth in Europe, particularly in sectors like financials, industrials, and healthcare, which make up a significant portion of its holdings. However, challenges such as rising interest rates, regulatory changes, or economic slowdowns in developed European markets could negatively impact the ETF's performance. Additionally, fluctuations in the performance of top holdings like ASML, Nestlé, and AstraZeneca may influence the fund's returns.
SPEU Top 10 Holdings
SPEU is leaning on a mix of European heavyweights, with ASML acting as the star engine, rising strongly and giving the fund a clear tilt toward high-end semiconductors. Health care is another key pillar: Roche is steadily adding gains, while Novartis is climbing but showing signs of fatigue, and AstraZeneca is clearly lagging and weighing on returns. On the financial side, HSBC and Banco Santander are rising and help balance the picture, while industrial giant Siemens is quietly supporting performance. Overall, it’s a diversified developed Europe play, but with notable strength in tech and health care leaders.
Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 3.86% | $27.72M | €552.35B | 80.43% | 76 Outperform | |
| HSBC Holdings | 2.15% | $15.45M | £259.35B | 47.17% | 80 Outperform | |
| Roche Holding AG | 1.88% | $13.50M | $346.09B | 29.07% | 73 Outperform | |
| Novartis AG | 1.64% | $11.75M | CHF210.70B | 17.72% | 80 Outperform | |
| Shell (UK) | 1.63% | $11.70M | £202.39B | 35.46% | 73 Outperform | |
| AstraZeneca | 1.57% | $11.28M | $259.57B | 10.58% | 80 Outperform | |
| Nestlé SA | 1.50% | $10.73M | CHF196.18B | 2.36% | 71 Outperform | |
| Siemens | 1.37% | $9.85M | €201.24B | 16.61% | 74 Outperform | |
| SAP SE | 1.34% | $9.60M | €213.80B | -20.05% | 66 Neutral | |
| Banco Santander | 1.34% | $9.58M | €182.11B | 42.25% | 73 Outperform |
SPEU Technical Analysis
Negative
―
Price Trends
56.06
Negative
55.07
Negative
53.57
Positive
Market Momentum
-0.39
Positive
36.35
Neutral
17.31
Positive
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For SPEU, the sentiment is Negative. The current price of undefined is equal to the 20-day moving average (MA) of 56.25, equal to the 50-day MA of 56.06, and equal to the 200-day MA of 53.57, indicating a neutral trend. The MACD of -0.39 indicates Positive momentum. The RSI at 36.35 is Neutral, neither overbought nor oversold. The STOCH value of 17.31 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for SPEU.
SPEU Peer Comparison
Comparison Results
Performance Comparison
SPEU
SPDR Portfolio Europe ETF
55.12
7.31
15.29%
VGK
Vanguard FTSE Europe ETF
―
―
―
EZU
iShares MSCI Eurozone ETF
―
―
―
DBEU
Xtrackers MSCI Europe Hedged Equity ETF
―
―
―
GSEU
Goldman Sachs ActiveBeta Europe Equity ETF
―
―
―
FLEE
Franklin FTSE Europe ETF
―
―
―
Glossary
BuyAn ETF rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF is likely to deliver higher returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldAn ETF rated as a "Hold" s expected to perform in line with the overall market or a specific benchmark. This rating indicates that the ETF is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellAn ETF rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the ETF may deliver lower returns compared to other ETFs in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
DisclaimerThis AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: ―
Table of Contents